Richard K. Cheng

5.1k total citations · 2 hit papers
163 papers, 2.5k citations indexed

About

Richard K. Cheng is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Richard K. Cheng has authored 163 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Cardiology and Cardiovascular Medicine, 57 papers in Surgery and 30 papers in Molecular Biology. Recurrent topics in Richard K. Cheng's work include Chemotherapy-induced cardiotoxicity and mitigation (41 papers), Cardiac Structural Anomalies and Repair (27 papers) and Heart Failure Treatment and Management (27 papers). Richard K. Cheng is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (41 papers), Cardiac Structural Anomalies and Repair (27 papers) and Heart Failure Treatment and Management (27 papers). Richard K. Cheng collaborates with scholars based in United States, United Kingdom and Netherlands. Richard K. Cheng's co-authors include Gregg C. Fonarow, Hina W. Chaudhry, Douglas Leedy, Deepak L. Bhatt, Mathew S. Maurer, Wayne C. Levy, Adrian F. Hernandez, Paul A. Heidenreich, Clyde W. Yancy and Zubin J. Eapen and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

Richard K. Cheng

143 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

2023 215 citations M. Kittleson, Frederick L. Ruberg et al. Journal of the American College of Cardiology profile →
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association

2024 57 citations Richard K. Cheng, M. Kittleson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard K. Cheng United States	24	1.1k	926	541	397	344	163	2.5k
Diego Bellavia Italy	25	1.3k 1.1×	646 0.7×	463 0.9×	120 0.3×	481 1.4×	63	2.1k
Gianluca Di Bella Italy	32	2.4k 2.2×	760 0.8×	640 1.2×	194 0.5×	406 1.2×	200	3.5k
Christian F. Vahl Germany	30	1.2k 1.1×	336 0.4×	945 1.7×	217 0.5×	804 2.3×	109	2.7k
Masahiko Hara Japan	28	570 0.5×	585 0.6×	459 0.8×	156 0.4×	455 1.3×	138	2.8k
Jin‐Ho Choi South Korea	29	854 0.8×	438 0.5×	1.4k 2.6×	148 0.4×	324 0.9×	112	2.8k
Atsushi Sakamoto Japan	39	738 0.7×	640 0.7×	1.0k 1.9×	151 0.4×	599 1.7×	138	4.7k
Ali E. Denktas United States	17	872 0.8×	396 0.4×	1.2k 2.2×	102 0.3×	326 0.9×	66	2.2k
G. Campion United Kingdom	19	718 0.6×	1.2k 1.3×	1.9k 3.5×	458 1.2×	89 0.3×	38	4.4k
Scipione Carerj Italy	31	3.2k 2.9×	418 0.5×	722 1.3×	178 0.4×	760 2.2×	218	4.2k
Yeong‐Hoon Choi Germany	34	1.6k 1.4×	880 1.0×	2.1k 4.0×	103 0.3×	629 1.8×	193	4.0k

Countries citing papers authored by Richard K. Cheng

Since Specialization

Citations

This map shows the geographic impact of Richard K. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard K. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard K. Cheng more than expected).

Fields of papers citing papers by Richard K. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard K. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard K. Cheng. The network helps show where Richard K. Cheng may publish in the future.

Co-authorship network of co-authors of Richard K. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Richard K. Cheng. A scholar is included among the top collaborators of Richard K. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard K. Cheng. Richard K. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ergas, Isaac J., Richard K. Cheng, Janise M. Roh, et al.. (2025). Diet quality and cardiometabolic health in breast cancer survivors: the Pathways Study. Breast Cancer Research and Treatment. 211(1). 139–150. 1 indexed citations

Lai, Carol, Petros Grivas, Shailender Bhatia, et al.. (2025). Successful treatment of immune checkpoint inhibitor-associated fulminant myocarditis with abatacept and ruxolitinib: a case report. European Heart Journal - Case Reports. 9(2). ytaf019–ytaf019. 5 indexed citations

Yu, Anthony F., Heather Landau, Xiaoyue Ma, et al.. (2025). Improvement in global longitudinal strain following plasma cell-directed therapy is associated with long-term survival among patients with AL amyloidosis. European Heart Journal Open. 5(5). oeaf104–oeaf104.

Kim, Paul, Jeffrey J. Teuteberg, Kiran K. Khush, et al.. (2025). Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection. JACC Heart Failure. 14(1). 102716–102716. 1 indexed citations

Huang, Yuhan, Marilyn L. Kwan, Susan R. Heckbert, et al.. (2025). Endocrine therapy and risk of cardiovascular disease and mortality in postmenopausal breast cancer survivors. JNCI Journal of the National Cancer Institute. 117(7). 1401–1409. 1 indexed citations

Ambardekar, Amrut V., Richard K. Cheng, Jan M. Griffin, et al.. (2025). Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance. Journal of the American College of Cardiology. 87(5). 549–565.

Cheng, Richard K., Arun Aggarwal, Vinyas Harish, et al.. (2024). Implementation considerations for the adoption of artificial intelligence in the emergency department. The American Journal of Emergency Medicine. 82. 75–81. 6 indexed citations

Lin, Shin, Ioannis Dimarakis, Elina Minami, et al.. (2024). Highly sensitized patients listed for heart after liver transplantation with or without domino. The Journal of Heart and Lung Transplantation. 44(1). 125–128. 2 indexed citations

Vasbinder, Alexi, Vidhushei Yogeswaran, Aladdin H. Shadyab, et al.. (2024). Life’s Essential 8 and Incident Cardiovascular Disease in U.S. Women With Breast Cancer. JACC CardioOncology. 6(5). 746–757. 5 indexed citations

10.

Vasbinder, Alexi, et al.. (2024). Reply. JACC CardioOncology. 6(6). 988–989.

11.

Leedy, Douglas, Eileen Rillamas‐Sun, Marilyn L. Kwan, et al.. (2024). Blood Pressure and Cardiovascular Risk in Women With Breast Cancer. SHILAP Revista de lepidopterología. 3(9). 101207–101207.

12.

Selvaraj, Senthil, Brian Claggett, Svati H. Shah, et al.. (2024). Cardiovascular Burden of the V142I Transthyretin Variant. JAMA. 331(21). 1824–1824. 17 indexed citations

13.

Bloom, Michelle, Jacqueline B. Vo, Jo E. Rodgers, et al.. (2024). Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America. Journal of Cardiac Failure. 31(2). 415–455. 10 indexed citations

14.

Akaike, Tomoko, Daniel S. Hippe, Michi M. Shinohara, et al.. (2022). Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review. Cancers. 14(23). 5914–5914.

15.

Vasbinder, Alexi, Oleg Zaslavsky, Susan R. Heckbert, et al.. (2022). Associations of Health-Related Quality of Life and Sleep Disturbance With Cardiovascular Disease Risk in Postmenopausal Breast Cancer Survivors. Cancer Nursing. 46(6). E355–E364. 1 indexed citations

16.

Berardi, Cecilia, David A. Bluemke, Brian A. Houston, et al.. (2022). Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study. The Journal of Heart and Lung Transplantation. 41(5). 619–625. 4 indexed citations

17.

Greenlee, Heather, Carlos Iribarren, Jamal S. Rana, et al.. (2022). Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. Journal of Clinical Oncology. 40(15). 1647–1658. 83 indexed citations

18.

Chatterjee, Neal A., Paul N. Jensen, Andrew Harris, et al.. (2021). Admission respiratory status predicts mortality in COVID‐19. Influenza and Other Respiratory Viruses. 15(5). 569–572. 39 indexed citations

19.

Kobo, Ofer, Sherry‐Ann Brown, Tarek Nafee, et al.. (2021). Impact of malignancy on In‐hospital mortality, stratified by the cause of admission: An analysis of 67 million patients from the National Inpatient Sample. International Journal of Clinical Practice. 75(11). e14758–e14758. 6 indexed citations

20.

Schueler, Stephan, Scott Silvestry, William Cotts, et al.. (2021). Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom. ESC Heart Failure. 8(4). 3049–3057. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact